The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review

Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn’s disease

(2019) Hannah S. Berman et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa

(2019) Christos C. Zouboulis et al.   DERMATOLOGY

Guselkumab for the treatment of psoriasis

(2018) Matteo Megna et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Guselkumab in the Treatment of Hidradenitis Suppurativa: A Retrospective Chart Review

(2018) Rachel G. Casseres et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Guselkumab in the treatment of severe Hidradenitis suppurativa

(2018) M Kovacs et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa

(2013) Alexa B. Kimball et al.   ANNALS OF INTERNAL MEDICINE

Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa

(2011) Christoph Schlapbach et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY